Old drug, new tricks: the unexpected effect of doxazosin on high-density lipoprotein.
Remaley
Alan T
AT
D064286:ATP Binding Cassette Transporter 1; D018528:ATP-Binding Cassette Transporters / Q000096:biosynthesis* / Q000235:genetics; D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D016632:Apolipoprotein A-I / Q000096:biosynthesis / Q000235:genetics; D016466:CHO Cells; D047369:Chromatin Immunoprecipitation; D006224:Cricetinae; D003412:Cricetulus; D017292:Doxazosin / Q000494:pharmacology*; D015870:Gene Expression; D006801:Humans; D008075:Lipoproteins, HDL / Q000096:biosynthesis* / Q000235:genetics; D008264:Macrophages / Q000166:cytology / Q000378:metabolism; D051379:Mice; D009154:Mutation; D011485:Protein Binding / Q000502:physiology; D018340:Receptors, Adrenergic, alpha-1 / Q000235:genetics / Q000378:metabolism; D020218:Response Elements / Q000502:physiology; D050656:Transcription Factor AP-2 / Q000235:genetics / Q000378:metabolism*; D014158:Transcription, Genetic / Q000187:drug effects / Q000502:physiology; D015533:Transcriptional Activation / Q000187:drug effects* / Q000502:physiology
D064286:ATP Binding Cassette Transporter 1; D018528:ATP-Binding Cassette Transporters; D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists; D016632:Apolipoprotein A-I; D008075:Lipoproteins, HDL; D018340:Receptors, Adrenergic, alpha-1; D050656:Transcription Factor AP-2; D017292:Doxazosin